PenderFund Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-190,925
Closed -$5.45M 176
2022
Q1
$5.45M Sell
190,925
-13,000
-6% -$318K 1.34% 29
2021
Q4
$7.13M Buy
203,925
+400
+0.2% +$10.7K 1.62% 24
2021
Q3
$7.19M Sell
203,525
-1,200
-0.6% -$34K 1.88% 23
2021
Q2
$7.45M Sell
204,725
-57,900
-22% -$1.75M 1.74% 29
2021
Q1
$10.5M Sell
262,625
-55,500
-17% -$1.63M 2.54% 14
2020
Q4
$8.4M Sell
318,125
-1,000
-0.3% -$18.7K 2.14% 16
2020
Q3
$6.38M Buy
+319,125
New +$5.5M 1.77% 20

Other funds holding BHC

PenderFund Capital Management's BHC Position: Q2 2022 in Review

PenderFund Capital Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 190,925 shares — an estimated $5.45M sold.

PenderFund Capital Management first reported a position in BHC in Q3 2020 and held it in 7 quarters. The position peaked at $10.5M in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • PenderFund Capital Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • PenderFund Capital Management sold 190,925 Bausch Health shares in Q2 2022, an estimated $5.45M.
  • PenderFund Capital Management first reported a position in Bausch Health in Q3 2020 and held it in 7 quarters.
  • PenderFund Capital Management's Bausch Health position peaked at $10.5M in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on PenderFund Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.